Clinical Trials Browser

birtamimab × Clear all

NCT02312206 2023-11-14

VITAL

Phase 3 Terminated

260 enrolled 11 charts

Immunoglobulin Light-chain Amyloidosis

NCT02613182 2019-05-16

OLE

Phase 2 Terminated

34 enrolled 10 charts

Immunoglobulin Light-chain Amyloidosis

NCT02632786 2019-04-05

PRONTO

Phase 2 Completed

129 enrolled 18 charts

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Paraproteinemias

NCT03154047 2019-03-26

Study in Subjects With Light Chain (AL) Amyloidosis

Phase 2 Terminated

80 enrolled 9 charts

Immunoglobulin Light-chain Amyloidosis

NCT01707264 2018-08-28

Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis

Phase 1/2 Completed

Immunoglobulin Light-chain Amyloidosis